Woodstock Corp Aldeyra Therapeutics, Inc. Transaction History

Woodstock Corp

$1.15 Billion
Q3 2025

A detailed history of Woodstock Corp transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Woodstock Corp holds 266,756 shares of ALDX stock, worth $1.35 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

266,756

Previous 266,756 -0.0%

Holding current value

$1.35 Million

Previous $1.02 Million 35.06%

% of portfolio

0.12%

Previous 0.09%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 09, 2025	BUY	$1.42 - $5.48 $62,000 - $239,267	43,662 Added 19.57%	266,756 $1.02 Million
Q1 2025 Apr 09, 2025	BUY	$4.7 - $6.98 $132,422 - $196,661	28,175 Added 14.45%	223,094 $1.49 Million
Q4 2024 Jan 15, 2025	BUY	$4.21 - $5.9 $59,415 - $83,266	14,113 Added 7.81%	194,919 $972,000
Q2 2024 Jul 08, 2024	BUY	$3.25 - $4.72 $32,795 - $47,629	10,091 Added 5.91%	180,806 $598,000
Q1 2024 Apr 09, 2024	BUY	$2.77 - $4.22 $149,610 - $227,926	54,011 Added 46.28%	170,715 $558,000

Q4 2023 Jan 08, 2024	SELL	$1.47 - $6.06 $30,098 - $124,078	-20,475 Reduced 14.93%	116,704 $409,000
Q4 2022 Jan 10, 2023	BUY	$5.08 - $7.09 $40,640 - $56,720	8,000 Added 6.19%	137,179 $0
Q3 2022 Oct 11, 2022	BUY	$3.8 - $7.74 $92,891 - $189,204	24,445 Added 23.34%	129,179 $690,000
Q2 2022 Jul 11, 2022	BUY	$2.43 - $4.85 $81,978 - $163,619	33,736 Added 47.52%	104,734 $418,000
Q1 2022 Apr 07, 2022	BUY	$3.25 - $5.17 $230,743 - $367,059	70,998 New	70,998 $316,000
Q4 2021 Jan 07, 2022	SELL	$3.5 - $9.63 $518,252 - $1.43 Million	-148,072 Closed	0 $0
Q2 2020 Jul 07, 2020	BUY	$1.97 - $5.05 $28,143 - $72,144	14,286 Added 10.68%	148,072 $617,000
Q4 2019 Jan 13, 2020	BUY	$4.73 - $7.98 $165,289 - $278,861	34,945 Added 35.35%	133,786 $777,000
Q1 2019 Apr 05, 2019	BUY	$7.14 - $9.85 $62,517 - $86,246	8,756 Added 9.72%	98,841 $893,000
Q4 2018 Jan 08, 2019	BUY	$7.26 - $13.29 $162,086 - $296,712	22,326 Added 32.95%	90,085 $748,000
Q1 2018 Apr 19, 2018	BUY	$6.55 - $8.9 $62,329 - $84,692	9,516 Added 16.34%	67,759 $508,000
Q4 2017 Jan 24, 2018	BUY	$5.7 - $7.75 $56,145 - $76,337	9,850 Added 20.35%	58,243 $396,000
Q3 2017 Oct 06, 2017	BUY	$3.9 - $10.8 $188,732 - $522,644	48,393	48,393 $348,000

Others Institutions Holding ALDX

# of Institutions

143

Shares Held

39.9M

Call Options Held

344K

Put Options Held

71.7K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $296M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodstock Corp, based on Form 13F filings with the SEC.

News

Stay updated on Woodstock Corp with notifications on news.

Account